Narcis Fuentes-Fernandez

Aberystwyth, WLS SY233DA, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 72 publications

Tisa-cel and axi-cel CAR structure influences the development of resistance to CD19-CAR-T therapy.

Tisa-cel and axi-cel CAR structure influences the development of resistance to CD19-CAR-T therapy.

Journal: Leukemia

Published: March 11, 2026

Oxidative stress-driven transcriptomic remodeling in human astrocytes reveals network signatures associated with neurodegenerative and cardiovascular processes.

Oxidative stress-driven transcriptomic remodeling in human astrocytes reveals network signatures associated with neurodegenerative and cardiovascular processes.

Journal: Computational and structural biotechnology journal

Published: November 14, 2025

NG2-ITGA4 axis regulates Rho GTPases and leukemic aggressiveness in KMT2A-r B-ALL and is targetable with natalizumab.

NG2-ITGA4 axis regulates Rho GTPases and leukemic aggressiveness in KMT2A-r B-ALL and is targetable with natalizumab.

Journal: Blood

Published: September 19, 2025

The costimulatory domain influences CD19 CAR-T cell resistance development in B-cell malignancies.

The costimulatory domain influences CD19 CAR-T cell resistance development in B-cell malignancies.

Journal: bioRxiv : the preprint server for biology

Published: March 17, 2025

Computational Design and Evaluation of Peptides to Target SARS-CoV-2 Spike-ACE2 Interaction.

Computational Design and Evaluation of Peptides to Target SARS-CoV-2 Spike-ACE2 Interaction.

Journal: Molecules (Basel, Switzerland)

Published: February 25, 2025

Preclinical development of three novel CARs targeting CD79b for the treatment of non-Hodgkin's lymphoma and characterization of the loss of the target antigen.

Preclinical development of three novel CARs targeting CD79b for the treatment of non-Hodgkin's lymphoma and characterization of the loss of the target antigen.

Journal: Journal for immunotherapy of cancer

Published: November 25, 2024

CAR-T cells targeting CCR9 and CD1a for the treatment of T cell acute lymphoblastic leukemia.

CAR-T cells targeting CCR9 and CD1a for the treatment of T cell acute lymphoblastic leukemia.

Journal: Journal of hematology & oncology

Published: November 05, 2024

LILRB1-directed CAR-T cells for the treatment of hematological malignancies.

LILRB1-directed CAR-T cells for the treatment of hematological malignancies.

Journal: Leukemia

Published: September 06, 2024

Halotolerant bacterial endophyte Bacillus velezensis CBE mediates abiotic stress tolerance with minimal transcriptional modifications in Brachypodium distachyon.

Halotolerant bacterial endophyte Bacillus velezensis CBE mediates abiotic stress tolerance with minimal transcriptional modifications in Brachypodium distachyon.

Journal: Frontiers in plant science

Published: August 23, 2024

A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR T-cell therapy in B-cell acute lymphoblastic leukemia.

A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR T-cell therapy in B-cell acute lymphoblastic leukemia.

Journal: Blood

Published: May 16, 2024

Defective ribosome assembly impairs leukemia progression in a murine model of acute myeloid leukemia.

Defective ribosome assembly impairs leukemia progression in a murine model of acute myeloid leukemia.

Journal: Cell reports

Published: April 16, 2024

Evolutionary analysis reveals the role of a non-catalytic domain of peptidyl arginine deiminase 2 in transcriptional regulation.

Evolutionary analysis reveals the role of a non-catalytic domain of peptidyl arginine deiminase 2 in transcriptional regulation.

Journal: iScience

Published: December 21, 2023

Showing 1-12 of 72

Last Updated: 09/26/2026